Daorong Wang

4.1k total citations · 1 hit paper
150 papers, 2.7k citations indexed

About

Daorong Wang is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Daorong Wang has authored 150 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 50 papers in Surgery and 50 papers in Molecular Biology. Recurrent topics in Daorong Wang's work include Colorectal Cancer Surgical Treatments (26 papers), Gastric Cancer Management and Outcomes (17 papers) and Colorectal Cancer Screening and Detection (16 papers). Daorong Wang is often cited by papers focused on Colorectal Cancer Surgical Treatments (26 papers), Gastric Cancer Management and Outcomes (17 papers) and Colorectal Cancer Screening and Detection (16 papers). Daorong Wang collaborates with scholars based in China, United States and Belgium. Daorong Wang's co-authors include Dong Tang, Dong Tang, Liuhua Wang, Huan Zhang, Zhilin Zhang, Sen Wang, Jingqiu Zhang, Xiaoqing Wu, Yongkun Li and Zhujiang Dai and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Annals of Oncology.

In The Last Decade

Daorong Wang

136 papers receiving 2.7k citations

Hit Papers

Regulatory role of short-chain fatty acids in inflammator... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daorong Wang China 30 1.2k 986 687 446 441 150 2.7k
Hisashi Onodera Japan 26 1.0k 0.8× 1.1k 1.1× 566 0.8× 446 1.0× 350 0.8× 87 2.5k
André Salim Khayat Brazil 31 938 0.8× 370 0.4× 844 1.2× 467 1.0× 143 0.3× 186 2.9k
Bo Jin China 26 710 0.6× 427 0.4× 450 0.7× 316 0.7× 127 0.3× 97 2.1k
Giuseppe Sica Italy 36 980 0.8× 771 0.8× 1.2k 1.7× 236 0.5× 932 2.1× 139 4.0k
Masataka Okuno Japan 28 862 0.7× 339 0.3× 395 0.6× 195 0.4× 214 0.5× 97 2.2k
Qiu Zhao China 25 754 0.6× 262 0.3× 284 0.4× 414 0.9× 271 0.6× 112 2.1k
Michael J. Weyant United States 31 668 0.5× 430 0.4× 1.2k 1.7× 401 0.9× 225 0.5× 137 3.3k
Ming‐Chih Chou Taiwan 27 520 0.4× 319 0.3× 355 0.5× 297 0.7× 169 0.4× 95 2.0k
Nazima Pathan United Kingdom 25 1.3k 1.1× 526 0.5× 347 0.5× 147 0.3× 459 1.0× 79 3.0k
Manuel Castro de Moura Spain 21 486 0.4× 400 0.4× 1.1k 1.6× 276 0.6× 250 0.6× 51 2.8k

Countries citing papers authored by Daorong Wang

Since Specialization
Citations

This map shows the geographic impact of Daorong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daorong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daorong Wang more than expected).

Fields of papers citing papers by Daorong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daorong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daorong Wang. The network helps show where Daorong Wang may publish in the future.

Co-authorship network of co-authors of Daorong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Daorong Wang. A scholar is included among the top collaborators of Daorong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daorong Wang. Daorong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Daorong, et al.. (2025). Cross-talks of GSH, mitochondria, RNA m6A modification, NRF2, and p53 between ferroptosis and cuproptosis in HCC: A review. International Journal of Biological Macromolecules. 302. 140523–140523. 6 indexed citations
3.
Liu, Guanghao, et al.. (2024). Methyltransferase DNMT3B promotes colorectal cancer cell proliferation by inhibiting PLCG2. Acta Biochimica et Biophysica Sinica. 56(12). 1848–1859. 4 indexed citations
4.
Sun, Qiannan, et al.. (2024). Retinol Binding Protein 4 Serves as a Potential Tumor Biomarker and Promotes Malignant Behavior in Gastric Cancer. Cancer Management and Research. Volume 16. 891–908. 3 indexed citations
5.
Xie, Xiangyu, et al.. (2024). ALKBH5 knockdown suppresses gastric cancer progression by reducing the expression of long non-coding RNA TUG1. Toxicology Research. 14(1). tfae209–tfae209. 1 indexed citations
6.
Wang, Jie, et al.. (2024). Robotic versus laparoscopic anterior resection for the treatment of stage II and III sigmoid colon cancer: a propensity score-matched analysis. Journal of Robotic Surgery. 18(1). 207–207. 1 indexed citations
7.
Zhang, Jingqiu, et al.. (2024). Changes in Intestinal Microbiota and Their Relationship With Patient Characteristics in Colorectal Cancer. Clinical Medicine Insights Oncology. 18. 1383428592–1383428592. 1 indexed citations
8.
Ren, Jun, Zhiqing Hu, Gengming Niu, et al.. (2023). Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR. The FASEB Journal. 37(3). e22790–e22790. 29 indexed citations
9.
Zhang, Wenjie, et al.. (2023). The huge potential of targeting copper status in the treatment of colorectal cancer. Clinical & Translational Oncology. 25(7). 1977–1990. 25 indexed citations
10.
Ma, Yue, et al.. (2023). Evaluation of the safety and efficacy of perform enterectomy in colorectal cancer patients aged 80 or older. A meta-analysis and a systematic review. International Journal of Colorectal Disease. 38(1). 185–185. 2 indexed citations
11.
Sun, Qiannan, et al.. (2023). Robotic-assisted intracorporeal versus extracorporeal techniques in sigmoidectomy: a propensity score-matched analysis. Journal of Robotic Surgery. 17(5). 2479–2485. 5 indexed citations
12.
13.
Zhao, Bin, Fang Fang, Yiqun Liao, et al.. (2023). Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. BMC Bioinformatics. 24(1). 100–100. 4 indexed citations
14.
Zhang, Wenjie, et al.. (2022). Galectins Are Central Mediators of Immune Escape in Pancreatic Ductal Adenocarcinoma. Cancers. 14(22). 5475–5475. 9 indexed citations
15.
Tang, Xiaoli, et al.. (2018). Robotic versus laparoscopic surgery for rectal cancer in male urogenital function preservation, a meta-analysis. World Journal of Surgical Oncology. 16(1). 196–196. 22 indexed citations
16.
Wang, Daorong, Minghao Xu, Dong Tang, et al.. (2018). Application value of the modified terminal cannula ileostomy in laparoscopic anus-preserving operation of low rectal cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 17(2). 188–193.
17.
Wang, Daorong, Chaowu Chen, Jie Chen, et al.. (2013). The Use of Propofol as a Sedative Agent in Gastrointestinal Endoscopy: A Meta-Analysis. PLoS ONE. 8(1). e53311–e53311. 111 indexed citations
18.
Yu, Haifeng, Daorong Wang, Yun Zhang, et al.. (2012). SFRP2 gene promoter hypermethylation and its clinicopathologic significance in colorectal carcinoma. 39(8). 526–529. 1 indexed citations
19.
Tang, Dong, Daorong Wang, Haifeng Yu, & Yongkun Li. (2010). The expression of hypermethylated secreted frizzled-related protein 2 gene in eolorectal cancer. Zhonghua putong waike zazhi. 25(6). 480–483. 2 indexed citations
20.
Wang, Daorong. (2009). Study of the role of methylated SFRP2 gene in colorectal cancer screening. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026